C1QTNF9 and coronary artery disorder: In contrast, levels of circulating CTRP9 were significantly increased patients with T2DM and CAD, suggesting a compensatory response to insulin resistance, inflammatory milieu and endothelial dysfunction (Moradi et al., 2018).